FPR as a prognostic biomarker in stage II and III gastric cancer

被引：0
|
作者：
Zhang, J. [1 ]
Wang, X-Z. [1 ]
Ying, H-Q. [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Fragmented Care in Stage II and III Gastric and Esophageal Cancer
    Eckhoff, Austin
    Rhodin, Kristen E.
    Creasy, John
    Kanu, Elsihama
    Beckhorn, Caherine
    Sutton, Linda
    Nussbaum, Daniel
    Allen, Peter J.
    Blazer, Dan G., III
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S150 - S150
  • [22] Intensive Radiographic and Biomarker Surveillance in Stage II and III Colorectal Cancer
    Fora, Ahmad
    Patta, Annie
    Attwood, Kristopher
    Wilding, Gregory
    Fakih, Marwan
    ONCOLOGY, 2012, 82 (01) : 41 - 47
  • [23] Prognostic biomarker in advanced gastric cancer
    Mi, Lan
    Ji, Xin
    Ji, Jiafu
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2016, 5 (01) : 16 - 29
  • [24] Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
    Li, Jialu
    Liu, Yang
    Wang, Cheng
    Deng, Ting
    Liang, Hongwei
    Wang, Yifei
    Huang, Dingzhi
    Fan, Qian
    Wang, Xia
    Ning, Tao
    Liu, Rui
    Zhang, Chen-Yu
    Zen, Ke
    Chen, Xi
    Ba, Yi
    SCIENTIFIC REPORTS, 2015, 5
  • [25] Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
    Jialu Li
    Yang Liu
    Cheng Wang
    Ting Deng
    Hongwei Liang
    Yifei Wang
    Dingzhi Huang
    Qian Fan
    Xia Wang
    Tao Ning
    Rui Liu
    Chen-Yu Zhang
    Ke Zen
    Xi Chen
    Yi Ba
    Scientific Reports, 5
  • [26] Prognostic Value of Fibrinogen to Prealbumin Ratio (FPR) in Resectable Gastric Cancer
    Li, Hongwei
    Sun, Yufei
    Wang, Cong
    Xue, Yingwei
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1325 - 1335
  • [27] A Novel Prognostic Biomarker Evaluated in Public Gene Expression Repositories is an Independent Prognostic Biomarker in Stage II Colorectal Cancer
    Hogan, J.
    Kalady, M.
    Coffey, J. C.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 88 - 88
  • [28] Response to Comment on "To Treat, or Not to Treat, That is the Question Biomarker-guided Adjuvant Chemotherapy for Stage II and III Gastric Cancer''
    Choi, Yoon Young
    Cheong, Jae-Ho
    ANNALS OF SURGERY, 2019, 270 (02) : E40 - E41
  • [29] Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
    Alkader, Mohammad S.
    Al-Majthoub, Murad Z.
    Al-Qerem, Walid A.
    Alkhader, Doaa M.
    Alhusban, Aseel M.
    Abdulkareem, Muna A.
    Abweny, Bashar
    Hamawi, Alaa T.
    Muslem, Hala F.
    Omesh, Rasha A.
    Al-Adwan, AlAnoud M.
    Al Halaiqah, Hamed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [30] Prognostic Impact of Mucinous Adenocarcinoma in Stage II and III Colon Cancer
    Kim, Seijong
    Huh, Jung Wook
    Lee, Woo Yong
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Cho, Yong Beom
    Park, Yoonah
    Shin, Jung Kyong
    DISEASES OF THE COLON & RECTUM, 2023, 66 (11) : 1473 - 1480
12345